HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
Previous close
$4.52
Day range
$4.23 - $4.51
Year range
$4.23 - $29.60
Market cap
88.83M USD
Avg Volume
218.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.00M | — |
Operating expense | 9.78M | -29.06% |
Net income | -27.13M | 17.49% |
Net profit margin | -2.71K | — |
Earnings per share | -1.30 | 60.61% |
EBITDA | -28.33M | 14.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 153.24M | 30.88% |
Total assets | 234.38M | 19.11% |
Total liabilities | 90.26M | -4.04% |
Total equity | 144.12M | — |
Shares outstanding | 20.80M | — |
Price to book | 0.65 | — |
Return on assets | -29.93% | — |
Return on capital | -31.81% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -27.13M | 17.49% |
Cash from operations | -21.12M | 11.66% |
Cash from investing | -13.35M | -173.34% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -34.47M | -492.17% |
Free cash flow | -11.77M | 36.71% |
About
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Founded
Jan 1, 2006
Headquarters
Website
Employees
121
